...
首页> 外文期刊>Neurosurgery >Embolization of cerebral arteriovenous malformations with cellulose acetate polymer: a clinical, radiological, and histological study.
【24h】

Embolization of cerebral arteriovenous malformations with cellulose acetate polymer: a clinical, radiological, and histological study.

机译:用醋酸纤维素聚合物栓塞脑动静脉畸形:临床,放射学和组织学研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: A cellulose acetate polymer (CAP) solution was hypothesized to be useful for the embolization of arteriovenous malformations (AVMs). To investigate this possibility, we analyzed the clinical, radiological, and histological results of patients with AVMs embolized by using a CAP solution. METHODS: We reviewed the cases of 11 patients with AVMs treated by embolization before surgical resection. We used two types of CAP solutions, CAP-M and CAP-L, which are mixtures of 250 mg of solid CAP and 1800 or 2250 mg of bismuth trioxide dissolved in 5.5 or 7.0 ml of dimethyl sulfoxide, respectively. After the embolization procedure, percent reduction of the nidus volume was measured, and thereafter, the clinical course and computed tomographic scans and/or magnetic resonance imaging scans were evaluated. All patients underwent surgical resection 1 to 51 days after embolization. Resected specimens were stained for light microscopic examination. RESULTS: Thirty-nine feeding vessels were embolized. The reduction rate of the nidus volume ranged from 20% to nearly 100%. Transient and persistent ischemic deficits occurred in three patients and one patient, respectively, and there were no hemorrhagic complications. All AVMs but one were completely resected by surgery. The embolized AVMs were soft enough to be easily cut and retracted. The histological examinations disclosed no or mild inflammatory reactions within 2 weeks after embolization. The internal elastic lamina was preserved in every case. Recanalization through the cast of the CAP mass was not observed until 51 days after embolization. CONCLUSION: CAP solution is a safe and useful embolic agent for AVMs.
机译:目的:醋酸纤维素聚合物(CAP)溶液被认为可用于栓塞动静脉畸形(AVM)。为了调查这种可能性,我们分析了通过使用CAP解决方案栓塞的AVM患者的临床,影像学和组织学结果。方法:我们回顾了11例经栓塞术治疗的AVM患者的手术切除情况。我们使用两种类型的CAP溶液:CAP-M和CAP-L,它们分别是250 mg固体CAP和1800或2250 mg三氧化二铋溶解在5.5或7.0 ml二甲基亚砜中的混合物。栓塞手术后,测量病灶体积缩小的百分比,然后评估临床病程和计算机断层扫描和/或磁共振成像扫描。所有患者在栓塞后1至51天接受手术切除。将切除的标本染色以进行光学显微镜检查。结果:39只饲管被栓塞。 nidus体积的减少率从20%到接近100%。短暂性和持续性缺血缺陷分别发生在3例和1例患者中,没有出血并发症。除一个以外的所有AVM均已通过手术切除。栓塞的AVM足够柔软,可以轻松切割和缩回。组织学检查显示栓塞后2周内无或有轻度炎症反应。在每种情况下均保留内部弹性薄片。直到栓塞后51天,才观察到通过CAP团铸件进行的再通。结论:CAP解决方案是一种安全有效的AVM栓塞剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号